Literature DB >> 1975733

Contribution of luminal ammoniagenesis to proximal tubule ammonia appearance in the rat.

E E Simon1, C Merli, J Herndon, L L Hamm.   

Abstract

The contribution of luminal ammoniagenesis in the late proximal convolute tubule (PCT) via phosphate-independent glutaminase [gamma-glutamyltransferase (gamma-GT)] remains controversial. If this pathway is important, it must rely on glutamine secretion, because filtered glutamine is reabsorbed in the early PCT. The contribution of gamma-GT to luminal ammoniagenesis was tested by use of in vivo microperfusion in conjunction with a new microfluorometric assay for glutamate. We first confirmed that aspartate completely blocked glutamate uptake in the PCT. Furthermore, the gamma-GT inhibitor acivicin completely eliminated glutamate entry, showing that passive glutamate entry was negligible. Thus the accumulation of glutamate can be used as an estimate of luminal glutamine deamidation. L-Phenylalanine was used to inhibit glutamine loss, and hippurate was used to stimulate gamma-GT activity; therefore luminal glutamine conversion to glutamate was promoted. Perfusing the tubule at 30 nl/min with a solution containing 10 mM each of hippurate, phenylalanine, and aspartate resulted in a glutamate delivery of 1.08 +/- 0.12 pmol.min-1.mm-1. Ammonia appearance was 10-fold higher, averaging 11.5 +/- 1.3 pmol.min-1.mm-1 under these same conditions. Thus the luminal conversion of glutamine to glutamate via gamma-GT is a small component of total ammoniagenesis in this segment.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1975733     DOI: 10.1152/ajprenal.1990.259.3.F402

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  2 in total

1.  Effects of methionine sulphoximine treatment on renal amino acid and ammonia metabolism in rats.

Authors:  S Heeneman; C H Dejong; N E Deutz
Journal:  Pflugers Arch       Date:  1994-07       Impact factor: 3.657

Review 2.  Renal ammonia metabolism and transport.

Authors:  I David Weiner; Jill W Verlander
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.